| Male, n [%] |
33 [61.1] |
20 [76.9] |
0.210 |
| Age of PD onset, mean [SD] Y |
65.2 [9.8] |
67.1 [10.4] |
0.334 |
| Age (at time of systemic inflammation), mean [SD] Y |
75.8 [7.0] |
76.0 [9.1] |
0.471 |
| PD duration, mean [SD] Y |
10.7 [6.4] |
8.9 [3.5] |
0.431 |
| Modified H–Y stage, n [%] |
2 |
7 [13.0] |
0 [0.0] |
0.151 |
|
2.5–3 |
27 [50.0] |
14 [53.8] |
|
|
4 |
20 [37.0] |
12 [46.2] |
|
| UPDRS-III score, mean [SD], n |
26.5 [12.4], 8 |
35.4 [9.2], 8 |
0.169 |
| Dementia, n [%] |
29 [53.7] |
17 [65.4] |
0.347 |
| MMSE score, mean [SD], n |
24.3 [4.3], 17 |
20.8 [6.0], 8 |
0.160 |
| History of psychosis, n [%] |
32 [59.3] |
22 [84.6] |
0.040 |
| Initial symptoms, non-tremor n [%] |
36 [66.7] |
22 [84.6] |
0.114 |
| Symptomatic orthostatic hypotension, n [%] |
12 [22.2] |
10 [38.5] |
0.181 |
| LED, median [range] mg/day |
600 [0–1673] |
481 [300–898] |
0.164 |
| Use of dopamine agonists, n [%] |
20 [37.0] |
4 [15.4] |
0.068 |
| Use of central anticholinergic drugs, n [%] |
4 [7.4] |
1 [3.8] |
1.000 |
| Delirium, n [%] |
10 [18.5] |
21 [80.8] |
<0.001 |
| Peak body temperature, mean [SD]°C |
37.8 [0.8] |
38.7 [0.8] |
<0.001 |
| Peak leukocyte count, mean [SD]×103/µl |
11.6 [2.9] |
12.4 [3.6] |
0.345 |
| Peak plasma CRP concentration, mean [SD] mg/dl |
8.5 [5.9] |
11.5 [6.9] |
0.057 |
| Duration of leukocytosis, n [%] |
1–3 days |
31 [58.5] |
7 [26.9] |
<0.001 |
|
4–8 days |
21 [39.6] |
6 [23.1] |
|
|
9–34 days |
1 [1.9] |
13 [50.0] |
|
